Review




Structured Review

PEPperPRINT gmbh pepperchip custom peptide microarray
Dot-plot between anti-CRP antibodies and epitope positivity. The graph displays anti-CRP antibodies versus the number of positive epitopes obtained with <t>microarray-based</t> linear epitope mapping in patients with systemic lupus erythematosus ( n =42). (CRP, C-reactive protein).
Pepperchip Custom Peptide Microarray, supplied by PEPperPRINT gmbh, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pepperchip custom peptide microarray/product/PEPperPRINT gmbh
Average 90 stars, based on 1 article reviews
pepperchip custom peptide microarray - by Bioz Stars, 2026-04
90/100 stars

Images

1) Product Images from "Mapping autoantibody targets of full-length C-reactive protein in systemic lupus erythematosus: importance for neutrophil function and classical complement activation"

Article Title: Mapping autoantibody targets of full-length C-reactive protein in systemic lupus erythematosus: importance for neutrophil function and classical complement activation

Journal: Frontiers in Immunology

doi: 10.3389/fimmu.2025.1578372

Dot-plot between anti-CRP antibodies and epitope positivity. The graph displays anti-CRP antibodies versus the number of positive epitopes obtained with microarray-based linear epitope mapping in patients with systemic lupus erythematosus ( n =42). (CRP, C-reactive protein).
Figure Legend Snippet: Dot-plot between anti-CRP antibodies and epitope positivity. The graph displays anti-CRP antibodies versus the number of positive epitopes obtained with microarray-based linear epitope mapping in patients with systemic lupus erythematosus ( n =42). (CRP, C-reactive protein).

Techniques Used: Microarray

Heatmap representation of autoreactivity against CRP obtained with microarray-based linear epitope mapping of the full CRP monomer. (A, B) Individual signal intensity of IgG autoantibody reactivity against full-length CRP for subjects with SLE ( n =42) and HBD ( n =11). (C–E) Mean signal intensity of IgG autoantibody reactivity against motifs of full-length CRP comparing anti-CRP negative (anti-CRP–; n =16) vs. anti-CRP positive (anti-CRP+; n =26) patients with SLE, patients with ( n =6) and without ( n =36) active disease, and no damage ( n =20) vs. irreversible organ damage (any organ system; n =22). Each column represents one subject (A, B) or the mean value of a group (C–E) . Each row represents a 15 amino acid long sequence covering the full length of the protein with 14 amino acids overlap and 7 amino acid GS repeats elongated before and after the protein sequence. (CRP, C-reactive protein; HBD, healthy blood donors; SDI, Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index; SLE, systemic lupus erythematosus; SLEDAI-2K, SLE Disease Activity Index 2000).
Figure Legend Snippet: Heatmap representation of autoreactivity against CRP obtained with microarray-based linear epitope mapping of the full CRP monomer. (A, B) Individual signal intensity of IgG autoantibody reactivity against full-length CRP for subjects with SLE ( n =42) and HBD ( n =11). (C–E) Mean signal intensity of IgG autoantibody reactivity against motifs of full-length CRP comparing anti-CRP negative (anti-CRP–; n =16) vs. anti-CRP positive (anti-CRP+; n =26) patients with SLE, patients with ( n =6) and without ( n =36) active disease, and no damage ( n =20) vs. irreversible organ damage (any organ system; n =22). Each column represents one subject (A, B) or the mean value of a group (C–E) . Each row represents a 15 amino acid long sequence covering the full length of the protein with 14 amino acids overlap and 7 amino acid GS repeats elongated before and after the protein sequence. (CRP, C-reactive protein; HBD, healthy blood donors; SDI, Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index; SLE, systemic lupus erythematosus; SLEDAI-2K, SLE Disease Activity Index 2000).

Techniques Used: Microarray, Sequencing, Activity Assay



Similar Products

90
PEPperPRINT gmbh pepperchip custom peptide microarray
Dot-plot between anti-CRP antibodies and epitope positivity. The graph displays anti-CRP antibodies versus the number of positive epitopes obtained with <t>microarray-based</t> linear epitope mapping in patients with systemic lupus erythematosus ( n =42). (CRP, C-reactive protein).
Pepperchip Custom Peptide Microarray, supplied by PEPperPRINT gmbh, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pepperchip custom peptide microarray/product/PEPperPRINT gmbh
Average 90 stars, based on 1 article reviews
pepperchip custom peptide microarray - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
PEPperPRINT gmbh pepperchip© custom peptide microarray
Dot-plot between anti-CRP antibodies and epitope positivity. The graph displays anti-CRP antibodies versus the number of positive epitopes obtained with <t>microarray-based</t> linear epitope mapping in patients with systemic lupus erythematosus ( n =42). (CRP, C-reactive protein).
Pepperchip© Custom Peptide Microarray, supplied by PEPperPRINT gmbh, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pepperchip© custom peptide microarray/product/PEPperPRINT gmbh
Average 90 stars, based on 1 article reviews
pepperchip© custom peptide microarray - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
PEPperPRINT gmbh pepperchip custom peptide microarrays
Dot-plot between anti-CRP antibodies and epitope positivity. The graph displays anti-CRP antibodies versus the number of positive epitopes obtained with <t>microarray-based</t> linear epitope mapping in patients with systemic lupus erythematosus ( n =42). (CRP, C-reactive protein).
Pepperchip Custom Peptide Microarrays, supplied by PEPperPRINT gmbh, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pepperchip custom peptide microarrays/product/PEPperPRINT gmbh
Average 90 stars, based on 1 article reviews
pepperchip custom peptide microarrays - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
PEPperPRINT gmbh custom peptide microarray pepperchip ©
Dot-plot between anti-CRP antibodies and epitope positivity. The graph displays anti-CRP antibodies versus the number of positive epitopes obtained with <t>microarray-based</t> linear epitope mapping in patients with systemic lupus erythematosus ( n =42). (CRP, C-reactive protein).
Custom Peptide Microarray Pepperchip ©, supplied by PEPperPRINT gmbh, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/custom peptide microarray pepperchip ©/product/PEPperPRINT gmbh
Average 90 stars, based on 1 article reviews
custom peptide microarray pepperchip © - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
PEPperPRINT gmbh pepperchip © custom peptide microarray
Dot-plot between anti-CRP antibodies and epitope positivity. The graph displays anti-CRP antibodies versus the number of positive epitopes obtained with <t>microarray-based</t> linear epitope mapping in patients with systemic lupus erythematosus ( n =42). (CRP, C-reactive protein).
Pepperchip © Custom Peptide Microarray, supplied by PEPperPRINT gmbh, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pepperchip © custom peptide microarray/product/PEPperPRINT gmbh
Average 90 stars, based on 1 article reviews
pepperchip © custom peptide microarray - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
PEPperPRINT gmbh pepperchip® custom peptide microarrays
Dot-plot between anti-CRP antibodies and epitope positivity. The graph displays anti-CRP antibodies versus the number of positive epitopes obtained with <t>microarray-based</t> linear epitope mapping in patients with systemic lupus erythematosus ( n =42). (CRP, C-reactive protein).
Pepperchip® Custom Peptide Microarrays, supplied by PEPperPRINT gmbh, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pepperchip® custom peptide microarrays/product/PEPperPRINT gmbh
Average 90 stars, based on 1 article reviews
pepperchip® custom peptide microarrays - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
PEPperPRINT gmbh custom pepperchip peptide microarray
Screening and selection of peptide binders to SARS-CoV-2 S protein. ( a ) Peptides P2-P11 represent wild-type versions of the original 27-mer ACE2 N-terminal alpha helix. They were designed as 18-mers spanning the length of the original fragment with 17 amino acids overlapped. The ACE2 fragment is predicted to bind to the SARS-CoV2 S protein via residues shown in bold . ( b ) Normalized binding signal of the ACE2-derived peptide variants show little to no binding to SARS-CoV2 S1 protein. There is an apparent trend for increased binding from the peptide fragments overlapping the center of the WT sequence and P7 shows the highest binding signal with a z-score of 1.3 when exposed to 50 µg/mL of S1 protein. ( c ) Normalized binding signal of the 14 peptides selected from <t>microarray</t> screening experiments for further characterization. 10 peptides were selected from the pool of ACE2 mutants, 3 were selected from the pool of modeled sequences, and one non-binding sequence was selected for comparison. All sequences selected had a Z-score > 2 on the 50 µg/mL S1 protein array, except for P481. ( d ) Sequences of the 14 peptides selected for synthesis with N-terminus biotin attached via a PEG4 spacer. **Note that P28 was not able to be synthesized by the vendor. ( e ) Binding curves of biotinylated peptides to immobilized SARS-CoV2 S1 protein in ELISA plate-based assay. Four peptides (P89, P100, P168 and P180) showed higher binding affinity than the original ACE2 fragment (SBP1) and were selected for further characterization.
Custom Pepperchip Peptide Microarray, supplied by PEPperPRINT gmbh, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/custom pepperchip peptide microarray/product/PEPperPRINT gmbh
Average 90 stars, based on 1 article reviews
custom pepperchip peptide microarray - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
PEPperPRINT gmbh pepperchip® custom peptide microarray chips
Screening and selection of peptide binders to SARS-CoV-2 S protein. ( a ) Peptides P2-P11 represent wild-type versions of the original 27-mer ACE2 N-terminal alpha helix. They were designed as 18-mers spanning the length of the original fragment with 17 amino acids overlapped. The ACE2 fragment is predicted to bind to the SARS-CoV2 S protein via residues shown in bold . ( b ) Normalized binding signal of the ACE2-derived peptide variants show little to no binding to SARS-CoV2 S1 protein. There is an apparent trend for increased binding from the peptide fragments overlapping the center of the WT sequence and P7 shows the highest binding signal with a z-score of 1.3 when exposed to 50 µg/mL of S1 protein. ( c ) Normalized binding signal of the 14 peptides selected from <t>microarray</t> screening experiments for further characterization. 10 peptides were selected from the pool of ACE2 mutants, 3 were selected from the pool of modeled sequences, and one non-binding sequence was selected for comparison. All sequences selected had a Z-score > 2 on the 50 µg/mL S1 protein array, except for P481. ( d ) Sequences of the 14 peptides selected for synthesis with N-terminus biotin attached via a PEG4 spacer. **Note that P28 was not able to be synthesized by the vendor. ( e ) Binding curves of biotinylated peptides to immobilized SARS-CoV2 S1 protein in ELISA plate-based assay. Four peptides (P89, P100, P168 and P180) showed higher binding affinity than the original ACE2 fragment (SBP1) and were selected for further characterization.
Pepperchip® Custom Peptide Microarray Chips, supplied by PEPperPRINT gmbh, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pepperchip® custom peptide microarray chips/product/PEPperPRINT gmbh
Average 90 stars, based on 1 article reviews
pepperchip® custom peptide microarray chips - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Dot-plot between anti-CRP antibodies and epitope positivity. The graph displays anti-CRP antibodies versus the number of positive epitopes obtained with microarray-based linear epitope mapping in patients with systemic lupus erythematosus ( n =42). (CRP, C-reactive protein).

Journal: Frontiers in Immunology

Article Title: Mapping autoantibody targets of full-length C-reactive protein in systemic lupus erythematosus: importance for neutrophil function and classical complement activation

doi: 10.3389/fimmu.2025.1578372

Figure Lengend Snippet: Dot-plot between anti-CRP antibodies and epitope positivity. The graph displays anti-CRP antibodies versus the number of positive epitopes obtained with microarray-based linear epitope mapping in patients with systemic lupus erythematosus ( n =42). (CRP, C-reactive protein).

Article Snippet: The full sequence of the CRP monomer was printed in 15 a.a sequences with 14 a.a overlap using PEPperCHIP Custom Peptide Microarray (PEPperPRINT ® GmbH, Heidelberg, Germany).

Techniques: Microarray

Heatmap representation of autoreactivity against CRP obtained with microarray-based linear epitope mapping of the full CRP monomer. (A, B) Individual signal intensity of IgG autoantibody reactivity against full-length CRP for subjects with SLE ( n =42) and HBD ( n =11). (C–E) Mean signal intensity of IgG autoantibody reactivity against motifs of full-length CRP comparing anti-CRP negative (anti-CRP–; n =16) vs. anti-CRP positive (anti-CRP+; n =26) patients with SLE, patients with ( n =6) and without ( n =36) active disease, and no damage ( n =20) vs. irreversible organ damage (any organ system; n =22). Each column represents one subject (A, B) or the mean value of a group (C–E) . Each row represents a 15 amino acid long sequence covering the full length of the protein with 14 amino acids overlap and 7 amino acid GS repeats elongated before and after the protein sequence. (CRP, C-reactive protein; HBD, healthy blood donors; SDI, Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index; SLE, systemic lupus erythematosus; SLEDAI-2K, SLE Disease Activity Index 2000).

Journal: Frontiers in Immunology

Article Title: Mapping autoantibody targets of full-length C-reactive protein in systemic lupus erythematosus: importance for neutrophil function and classical complement activation

doi: 10.3389/fimmu.2025.1578372

Figure Lengend Snippet: Heatmap representation of autoreactivity against CRP obtained with microarray-based linear epitope mapping of the full CRP monomer. (A, B) Individual signal intensity of IgG autoantibody reactivity against full-length CRP for subjects with SLE ( n =42) and HBD ( n =11). (C–E) Mean signal intensity of IgG autoantibody reactivity against motifs of full-length CRP comparing anti-CRP negative (anti-CRP–; n =16) vs. anti-CRP positive (anti-CRP+; n =26) patients with SLE, patients with ( n =6) and without ( n =36) active disease, and no damage ( n =20) vs. irreversible organ damage (any organ system; n =22). Each column represents one subject (A, B) or the mean value of a group (C–E) . Each row represents a 15 amino acid long sequence covering the full length of the protein with 14 amino acids overlap and 7 amino acid GS repeats elongated before and after the protein sequence. (CRP, C-reactive protein; HBD, healthy blood donors; SDI, Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index; SLE, systemic lupus erythematosus; SLEDAI-2K, SLE Disease Activity Index 2000).

Article Snippet: The full sequence of the CRP monomer was printed in 15 a.a sequences with 14 a.a overlap using PEPperCHIP Custom Peptide Microarray (PEPperPRINT ® GmbH, Heidelberg, Germany).

Techniques: Microarray, Sequencing, Activity Assay

Screening and selection of peptide binders to SARS-CoV-2 S protein. ( a ) Peptides P2-P11 represent wild-type versions of the original 27-mer ACE2 N-terminal alpha helix. They were designed as 18-mers spanning the length of the original fragment with 17 amino acids overlapped. The ACE2 fragment is predicted to bind to the SARS-CoV2 S protein via residues shown in bold . ( b ) Normalized binding signal of the ACE2-derived peptide variants show little to no binding to SARS-CoV2 S1 protein. There is an apparent trend for increased binding from the peptide fragments overlapping the center of the WT sequence and P7 shows the highest binding signal with a z-score of 1.3 when exposed to 50 µg/mL of S1 protein. ( c ) Normalized binding signal of the 14 peptides selected from microarray screening experiments for further characterization. 10 peptides were selected from the pool of ACE2 mutants, 3 were selected from the pool of modeled sequences, and one non-binding sequence was selected for comparison. All sequences selected had a Z-score > 2 on the 50 µg/mL S1 protein array, except for P481. ( d ) Sequences of the 14 peptides selected for synthesis with N-terminus biotin attached via a PEG4 spacer. **Note that P28 was not able to be synthesized by the vendor. ( e ) Binding curves of biotinylated peptides to immobilized SARS-CoV2 S1 protein in ELISA plate-based assay. Four peptides (P89, P100, P168 and P180) showed higher binding affinity than the original ACE2 fragment (SBP1) and were selected for further characterization.

Journal: Scientific Reports

Article Title: A high-throughput pipeline for design and selection of peptides targeting the SARS-Cov-2 Spike protein

doi: 10.1038/s41598-021-01225-2

Figure Lengend Snippet: Screening and selection of peptide binders to SARS-CoV-2 S protein. ( a ) Peptides P2-P11 represent wild-type versions of the original 27-mer ACE2 N-terminal alpha helix. They were designed as 18-mers spanning the length of the original fragment with 17 amino acids overlapped. The ACE2 fragment is predicted to bind to the SARS-CoV2 S protein via residues shown in bold . ( b ) Normalized binding signal of the ACE2-derived peptide variants show little to no binding to SARS-CoV2 S1 protein. There is an apparent trend for increased binding from the peptide fragments overlapping the center of the WT sequence and P7 shows the highest binding signal with a z-score of 1.3 when exposed to 50 µg/mL of S1 protein. ( c ) Normalized binding signal of the 14 peptides selected from microarray screening experiments for further characterization. 10 peptides were selected from the pool of ACE2 mutants, 3 were selected from the pool of modeled sequences, and one non-binding sequence was selected for comparison. All sequences selected had a Z-score > 2 on the 50 µg/mL S1 protein array, except for P481. ( d ) Sequences of the 14 peptides selected for synthesis with N-terminus biotin attached via a PEG4 spacer. **Note that P28 was not able to be synthesized by the vendor. ( e ) Binding curves of biotinylated peptides to immobilized SARS-CoV2 S1 protein in ELISA plate-based assay. Four peptides (P89, P100, P168 and P180) showed higher binding affinity than the original ACE2 fragment (SBP1) and were selected for further characterization.

Article Snippet: The library of 2,376 sequences was printed onto a custom PEPperCHIP peptide microarray (PEPperPrint GmbH, Heidelberg, Germany).

Techniques: Selection, Binding Assay, Derivative Assay, Sequencing, Microarray, Comparison, Protein Array, Synthesized, Enzyme-linked Immunosorbent Assay

Peptide Microarray to Identify SARS-CoV-2 S Protein Binding Sequences. ( a ) Schematic showing microarray screening procedure for detecting binding of a biotinylated target protein. ( b ) Microarray images of peptide subarray following exposure to 50, 10, or 5 µg/mL of SARS-CoV2 S1 protein. ( c ) Normalized binding signal of peptides after exposure to SARS-CoV2 S1 protein at 50, 10, or 5 µg/mL concentration. Z-score at each S1 concentration is plotted for peptides listed in numerical order along the X-axis. P2-P811 correspond to peptides derived from the ACE2 N-terminal alpha helix (approach 1) while P812-P2376 were derived from a random starting library and screened in silico for docking to S protein (approach 2). Peptides with high Z-scores (> 1.95, indicated by dotted line) represent S1 protein binding sequences.

Journal: Scientific Reports

Article Title: A high-throughput pipeline for design and selection of peptides targeting the SARS-Cov-2 Spike protein

doi: 10.1038/s41598-021-01225-2

Figure Lengend Snippet: Peptide Microarray to Identify SARS-CoV-2 S Protein Binding Sequences. ( a ) Schematic showing microarray screening procedure for detecting binding of a biotinylated target protein. ( b ) Microarray images of peptide subarray following exposure to 50, 10, or 5 µg/mL of SARS-CoV2 S1 protein. ( c ) Normalized binding signal of peptides after exposure to SARS-CoV2 S1 protein at 50, 10, or 5 µg/mL concentration. Z-score at each S1 concentration is plotted for peptides listed in numerical order along the X-axis. P2-P811 correspond to peptides derived from the ACE2 N-terminal alpha helix (approach 1) while P812-P2376 were derived from a random starting library and screened in silico for docking to S protein (approach 2). Peptides with high Z-scores (> 1.95, indicated by dotted line) represent S1 protein binding sequences.

Article Snippet: The library of 2,376 sequences was printed onto a custom PEPperCHIP peptide microarray (PEPperPrint GmbH, Heidelberg, Germany).

Techniques: Peptide Microarray, Protein Binding, Microarray, Binding Assay, Concentration Assay, Derivative Assay, In Silico